← Open Payments lookup

FLETCHER PEAVY: Open Payments

NPI 1437869526 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,473 in 67 payments from 16 companies in 2025. Trend: 2023 $1,183 · 2024 $1,843 · 2025 $1,473

Food & beverage: $1,389Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.16$255
Gilead Sciences, Inc.10$240
Celltrion USA Inc.8$165
Janssen Scientific Affairs, LLC1$138
GENZYME CORPORATION7$113
Ipsen Biopharmaceuticals, Inc5$109
ABBVIE INC.4$102
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$94
Intra-Sana Laboratories1$50
Intercept Pharmaceuticals, Inc.2$47

Products named: TREMFYA, VEGZELMA, DUPIXENT, IQIRVO, XIFAXAN, SKYRIZI, RELTONE 200 MG, OCALIVA.

Industry payments across NV — which companies pay providers there.